Oaktree Acquisition Corp. III Life Sciences (OACC) Competitors $10.44 -0.01 (-0.10%) As of 07/3/2025 12:39 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock OACC vs. ORC, NXRT, PAX, NOAH, AC, TINV, PLYM, GETY, AACT, and BRSPShould you be buying Oaktree Acquisition Corp. III Life Sciences stock or one of its competitors? The main competitors of Oaktree Acquisition Corp. III Life Sciences include Orchid Island Capital (ORC), NexPoint Residential Trust (NXRT), Patria Investments (PAX), Noah (NOAH), Associated Capital Group (AC), Tiga Acquisition (TINV), Plymouth Industrial REIT (PLYM), Getty Images (GETY), Ares Acquisition Corporation II (AACT), and BrightSpire Capital (BRSP). These companies are all part of the "trading" industry. Oaktree Acquisition Corp. III Life Sciences vs. Its Competitors Orchid Island Capital NexPoint Residential Trust Patria Investments Noah Associated Capital Group Tiga Acquisition Plymouth Industrial REIT Getty Images Ares Acquisition Corporation II BrightSpire Capital Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Orchid Island Capital (NYSE:ORC) are both small-cap trading companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk. Do analysts rate OACC or ORC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oaktree Acquisition Corp. III Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Orchid Island Capital 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media prefer OACC or ORC? In the previous week, Orchid Island Capital had 1 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 2 mentions for Orchid Island Capital and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 0.67 beat Orchid Island Capital's score of 0.53 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oaktree Acquisition Corp. III Life Sciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Orchid Island Capital 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of OACC or ORC? 32.7% of Orchid Island Capital shares are held by institutional investors. 0.4% of Orchid Island Capital shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better valuation and earnings, OACC or ORC? Orchid Island Capital has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AOrchid Island Capital$241.58M3.59$37.66M$0.4017.88 Is OACC or ORC more profitable? Orchid Island Capital's return on equity of 1.52% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A Orchid Island Capital N/A 1.52%0.17% SummaryOrchid Island Capital beats Oaktree Acquisition Corp. III Life Sciences on 7 of the 8 factors compared between the two stocks. Get Oaktree Acquisition Corp. III Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for OACC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OACC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OACC vs. The Competition Export to ExcelMetricOaktree Acquisition Corp. III Life Sciences Industry SectorNASDAQ ExchangeMarket Cap$234.13M$2.02B$2.00B$9.05BDividend YieldN/A13.74%13.71%4.03%P/E RatioN/A12.3912.0220.22Price / SalesN/A2,149,915.981,945,417.08118.64Price / CashN/A1,960.261,147.2058.07Price / BookN/A3.4510.525.67Net IncomeN/A-$414.85M-$260.24M$249.13M7 Day Performance-0.50%1.04%1.02%3.28%1 Month Performance-0.76%2.83%2.78%5.55%1 Year PerformanceN/A7.16%7.95%21.12% Oaktree Acquisition Corp. III Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OACCOaktree Acquisition Corp. III Life SciencesN/A$10.44-0.1%N/AN/A$234.13MN/A0.00N/ANews CoveragePositive NewsORCOrchid Island Capital4.0663 of 5 stars$7.07-0.4%N/A-14.2%$859.39M$241.58M17.662,018News CoverageHigh Trading VolumeNXRTNexPoint Residential Trust4.8804 of 5 stars$33.21+0.2%$43.58+31.2%-12.0%$838.44M$259.70M-25.953Positive NewsHigh Trading VolumePAXPatria Investments2.3142 of 5 stars$13.72-0.4%$14.00+2.0%+14.8%$832.00M$390.10M27.44390High Trading VolumeNOAHNoah3.3705 of 5 stars$12.01-2.4%$12.00-0.1%+43.2%$814.53M$356.33M12.381,990Positive NewsGap DownACAssociated Capital Group1.9524 of 5 stars$37.62-0.1%N/A+15.0%$795.83M$13.18M21.0220TINVTiga AcquisitionN/A$22.40+1.6%N/A+89.3%$772.80MN/A0.00N/AHigh Trading VolumePLYMPlymouth Industrial REIT4.0284 of 5 stars$16.12-1.6%$21.10+30.9%-24.0%$746.08M$198.35M5.2940Analyst UpgradeHigh Trading VolumeGETYGetty Images2.9013 of 5 stars$1.72-2.0%$4.35+153.6%-44.1%$723.48M$939.29M-9.031,700Analyst UpgradeAnalyst RevisionHigh Trading VolumeAACTAres Acquisition Corporation IIN/A$11.300.0%N/A+5.8%$699.02MN/A0.00N/ABRSPBrightSpire Capital3.0215 of 5 stars$5.26-0.1%$7.15+36.1%-9.9%$686.23M$244.77M-9.3850News Coverage Related Companies and Tools Related Companies Orchid Island Capital Competitors NexPoint Residential Trust Competitors Patria Investments Competitors Noah Competitors Associated Capital Group Competitors Tiga Acquisition Competitors Plymouth Industrial REIT Competitors Getty Images Competitors Ares Acquisition Corporation II Competitors BrightSpire Capital Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OACC) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.